Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

The African Pharmaceutical Market is projected to grow at an impressive CAGR of 6-8% by 2029, driven by a booming population, ...

Dr. Lily Ackermann discussed inpatient diabetes care, focusing on real-world decisions and personalized treatment using ...

The Saudi Arabia diabetes market reached a value of USD 373.4 million in 2024 and is projected to grow to USD 494.4 million by 2033, exhibiting a steady compound annual growth rate (CAGR) of 3.17% ...

Suzhou-based Innovent Biologics secured approval last week for its treatment mazdutide. Read more at straitstimes.com. Read ...

China’s nascent weight loss drug market is poised for rapid growth ... weekly injections peddled by Novo and Lilly. Leading insulin producer Gan & Lee Pharmaceutical is pushing ahead a longer-acting ...

A study finds that inhaled insulin is as effective as traditional injections for children with type 1 diabetes during ...

“Inhaled insulin can quickly get to the carbohydrates that are in the bloodstream, get them into the cells and out of the ...

CHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...

The endocrinologist and researcher was one of several investigators who presented Phase 3 clinical trial results at the 85th Scientific Sessions of the American Diabetes Association for a long-lasting ...

New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...

Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, ...